Drugs / Neovletta 21/28
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01110525 | May → Oct 2010 | — | AstraZeneca | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Neovletta 21/28 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01110525 ↗ |